Core Laboratories Inc.
CLB
$12.38
-$0.29-2.29%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 0.70% | 1.32% | 2.76% | 2.68% | 0.78% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 0.70% | 1.32% | 2.76% | 2.68% | 0.78% |
| Cost of Revenue | 2.59% | 3.07% | 5.14% | 4.42% | 1.27% |
| Gross Profit | -6.39% | -5.24% | -5.92% | -3.53% | -1.00% |
| SG&A Expenses | 4.56% | 17.66% | -0.78% | -2.82% | -2.68% |
| Depreciation & Amortization | -4.47% | -4.85% | -5.26% | -5.13% | -4.99% |
| Other Operating Expenses | -37.65% | -244.83% | -92.05% | -100.32% | -18.98% |
| Total Operating Expenses | 2.40% | 3.46% | 4.04% | 3.19% | 0.65% |
| Operating Income | -13.37% | -15.13% | -7.56% | -1.32% | 1.91% |
| Income Before Tax | 5.44% | -1.04% | 12.08% | 6.59% | -5.45% |
| Income Tax Expenses | -22.84% | 169.86% | 235.34% | 1,130.01% | 427.21% |
| Earnings from Continuing Operations | 24.15% | -24.53% | -13.16% | -34.31% | -38.72% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 7.19% | -28.13% | -115.14% | -1,607.41% | -187.16% |
| Net Income | 24.98% | -25.31% | -14.38% | -36.46% | -39.97% |
| EBIT | -13.37% | -15.13% | -7.56% | -1.32% | 1.91% |
| EBITDA | -11.43% | -12.98% | -7.06% | -2.16% | 0.33% |
| EPS Basic | 24.60% | -25.94% | -15.08% | -36.83% | -40.30% |
| Normalized Basic EPS | -12.48% | -18.60% | -12.12% | -8.18% | -7.16% |
| EPS Diluted | 27.27% | -23.99% | -12.65% | -36.53% | -41.44% |
| Normalized Diluted EPS | -12.29% | -18.48% | -12.22% | -8.22% | -7.33% |
| Average Basic Shares Outstanding | 0.04% | 0.32% | 0.48% | 0.76% | 0.83% |
| Average Diluted Shares Outstanding | -0.46% | -0.13% | 0.47% | 0.75% | 0.95% |
| Dividend Per Share | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Payout Ratio | -0.20% | 0.34% | 0.17% | 0.58% | 0.68% |